Lipoprotein(a) Concentration and Cardiovascular Disease in a Group of Patients With Familial Hypercholesterolemia—A Lipid Clinic Experience

Documenti analoghi

• Lipid‐Lowering Effect and Safety of Ezetimibe and Atorvastatin 5 mg in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia: A Randomized, Double‐Blind, Parallel, Multicenter, Phase 3 Clinical Trial
  di: You‐Jeong Ki, et al.
  Pubblicazione: (2025)
• Low‐Density Lipoprotein Cholesterol, Cardiovascular Risk Factors, and Predicted Risk in Young Adults
  di: Alexander R. Zheutlin, et al.
  Pubblicazione: (2024)
• Is There a Need for Sex‐Tailored Lipoprotein(a) Cut‐Off Values for Coronary Artery Disease Risk Stratification?
  di: Ece Yurtseven, et al.
  Pubblicazione: (2024)
• Home Heart Hospital Associated With Reduced Hospitalizations and Costs Among High‐Cost Patients With Cardiovascular Disease
  di: Michael Shen, et al.
  Pubblicazione: (2024)
• Trends in Mortality Due to Cardiovascular Diseases Among Patients With Parkinson's Disease in the United States: A Retrospective Analysis
  di: Muzamil Akhtar, et al.
  Pubblicazione: (2025)